Literature DB >> 31755986

A simplified composite outcome measure to assess the effect of periodontal regenerative treatment in intraosseous defects.

Leonardo Trombelli1,2, Roberto Farina1,2, Renata Vecchiatini2, Elisa Maietti3,4, Anna Simonelli1.   

Abstract

BACKGROUND: To propose a novel composite outcome measure (COM) for periodontal regenerative treatment of intraosseous defects.
METHODS: COM is based on the combination of clinically relevant clinical attachment level (CAL) gain (≥3 mm) and pocket closure (post-surgery probing depth [PD] ≤ 4 mm). Treatment was regarded as successful when a clinically relevant CAL gain was associated with pocket closure, and failing when either clinically relevant CAL gain and pocket closure were not achieved. The effect of the different regenerative treatments was both collectively and separately evaluated according to COM in a defect cohort accessed by Single Flap Approach (SFA).
RESULTS: In the entire study cohort, the procedure resulted in a 6-month CAL gain of 3.7 ± 1.9 mm, which was clinically relevant in 71.8% of patients. Six-month residual PD was 3.7 ± 1.1 mm, with pocket closure recorded in 79.6% of patients. COM revealed a successful treatment in 60 patients (58%), and a treatment failure in 7 patients (7%). Mean CAL gain was clinically relevant for each treatment, whereas the residual PD values were consistent with pocket closure for the majority of treatment options. However, when COM was used to rate the treatment outcome of each procedure, it appeared that a successful treatment ranged from 41.5% to 77.5%, whereas treatment failure varied from 3% to 15% for different treatments.
CONCLUSIONS: Compared to single probing measurements, COM seems (1) more accurate in capturing the overall benefit of the regenerative procedure and (2) to better identify which factor (CAL gain, residual pocket) mainly contributed to determine a treatment failure.
© 2019 American Academy of Periodontology.

Entities:  

Keywords:  periodontal attachment loss; periodontal diseases; periodontitis; reconstructive surgical procedures; treatment outcome

Year:  2020        PMID: 31755986     DOI: 10.1002/JPER.19-0127

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  8 in total

1.  Efficacy of periodontal minimally invasive surgery with and without regenerative materials for treatment of intrabony defect: a randomized clinical trial.

Authors:  Bei Liu; Xiangying Ouyang; Jun Kang; Shuangying Zhou; Chao Suo; Lingqiao Xu; Jianru Liu; Wenyi Liu
Journal:  Clin Oral Investig       Date:  2021-08-20       Impact factor: 3.573

2.  Periodontal surgery using rhFGF-2 with deproteinized bovine bone mineral or rhFGF-2 alone: 2-year follow-up of a randomized controlled trial.

Authors:  Hideto Aoki; Takahiro Bizenjima; Fumi Seshima; Masahiro Sato; Daisuke Irokawa; Kouki Yoshikawa; Wataru Yoshida; Kentaro Imamura; Daisuke Matsugami; Yurie Kitamura; Daichi Kita; Hiroki Sugito; Sachiyo Tomita; Atsushi Saito
Journal:  J Clin Periodontol       Date:  2020-11-12       Impact factor: 8.728

3.  Extracellular matrix containing nanocomposite bone graft in periodontal regeneration - A randomized controlled clinical and radiographic evaluation.

Authors:  Abhinav Prakash Deshpande; Mala Dixit Baburaj; Lashika Vasant Tambe; Upendra Prasad
Journal:  J Indian Soc Periodontol       Date:  2021-07-01

4.  The granulation tissue preservation technique in regenerative periodontal surgery-a randomized controlled clinical trial.

Authors:  Knut Adam; Hüsamettin Günay; Bernhard Vaske; Marco Flohr; Ingmar Staufenbiel
Journal:  Clin Exp Dent Res       Date:  2022-01-11

5.  Apical approach in periodontal reconstructive surgery with enamel matrix derivate and enamel matrix derivate plus bone substitutes: a randomized, controlled clinical trial.

Authors:  Jose Antonio Moreno Rodríguez; Antonio José Ortiz Ruiz
Journal:  Clin Oral Investig       Date:  2021-11-17       Impact factor: 3.606

6.  An exploratory clinical trial to evaluate the safety and efficacy of combination therapy of REGROTH® and Cytrans® granules for severe periodontitis with intrabony defects.

Authors:  Masahiro Kitamura; Motozo Yamashita; Koji Miki; Kuniko Ikegami; Masahide Takedachi; Yoichiro Kashiwagi; Takenori Nozaki; Katsuyuki Yamanaka; Hijiri Masuda; Yoko Ishihara; Shinya Murakami
Journal:  Regen Ther       Date:  2022-06-21       Impact factor: 3.651

7.  Single flap approach with or without enamel matrix derivative in the treatment of severe supraosseous defects: a retrospective study.

Authors:  Anna Simonelli; Luigi Minenna; Leonardo Trombelli; Roberto Farina
Journal:  Clin Oral Investig       Date:  2021-04-14       Impact factor: 3.573

8.  Long-term clinical outcomes of periodontal regeneration with enamel matrix derivative: A retrospective cohort study with a mean follow-up of 10 years.

Authors:  Siro P De Ry; Andrea Roccuzzo; Niklaus P Lang; Anton Sculean; Giovanni E Salvi
Journal:  J Periodontol       Date:  2021-09-08       Impact factor: 4.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.